oxybutynin has been researched along with Rubeola in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Excerpt | Relevance | Reference |
---|---|---|
"MAPs to deliver measles and rubella vaccines have the potential to be a transformative technology to achieve elimination goals in the African Region." | 2.66 | Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa. ( Moss, WJ; Richardson, LC, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Richardson, LC | 1 |
Moss, WJ | 1 |
Edens, C | 1 |
Collins, ML | 1 |
Ayers, J | 1 |
Rota, PA | 1 |
Prausnitz, MR | 1 |
1 review available for oxybutynin and Rubeola
Article | Year |
---|---|
Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa.
Topics: Administration, Cutaneous; Africa; Humans; Immunization Programs; Measles; Measles Vaccine; Microtec | 2020 |
1 other study available for oxybutynin and Rubeola
Article | Year |
---|---|
Measles vaccination using a microneedle patch.
Topics: Animals; Antibodies, Bacterial; Antibodies, Neutralizing; Antibody Formation; Dose-Response Relation | 2013 |